Screener
Integra LifeSciences IART Goodwill impairment
Goodwill impairment at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 24,253 | 26,997 | 47,754 | 51,725 |
| Selling, general and administrative | 172,436 | 179,890 | 350,671 | 361,387 |
| Intangible asset amortization | 3,770 | 3,754 | 7,546 | 7,458 |
| Goodwill impairment charge | — | 511,365 | — | 511,365 |
| Total costs and expenses | 399,476 | 928,279 | 779,924 | 1,326,429 |
| Operating income (loss) | 19,285 | (512,674) | 30,755 | (528,171) |
| Interest income | 4,267 | 4,710 | 8,372 | 9,130 |
| Interest expense | (22,994) | (21,042) | (45,459) | (39,857) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's goodwill impairment?
- Integra LifeSciences (IART) reported goodwill impairment of $0 in Q2 2026.
- How has Integra LifeSciences's goodwill impairment changed year-over-year?
- Integra LifeSciences's goodwill impairment decreased by 100.0% year-over-year, from $511.4M to $0.
- What does goodwill impairment mean?
- Write-down of goodwill carrying value when a reporting unit's fair value falls below its book value, indicating that past acquisitions have lost value.
Ask your AI about Integra LifeSciences's goodwill impairment.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude